Industry:Biotech & Pharma
Optimer Pharmaceuticals Inc
Optimer Pharmaceuticals Inc (OPTR:US)
was acquired by CBST:US
Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.